Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Covid Flu A/B and RSV 4 in 1 Diagnostic Test

ClinicalTrials.gov ID: NCT07308158

Public ClinicalTrials.gov record NCT07308158. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Human Factors and Clinical Validation of the iHealth Labs Inc iHealth Flu A&B/COVID-19/RSV Rapid Test in Anterior Nares Nasal Samples For Over the Counter (OTC) Use

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this observational study is to evaluate the diagnostic performance of an investigational Flu A/B, COVID-19 and RSV test in patients with signs and symptoms of respiratory infection. The main questions it aims to answer are: 1. What is the sensitivity and specificity of the investigational test compared with an FDA-cleared reference method for detection of Influenza A, Influenza B, , SARS-CoV-2 and respiratory syncytial virus antigen. 2. What is the overall positive and negative percent agreement between the investigational test and the reference method? Participants will: 1. Provide a respiratory specimen (e.g., nasal or nasopharyngeal swab) for testing with the investigational device. 2. Provide an additional specimen for testing with the FDA-cleared reference method.

Study identification

NCT ID
NCT07308158
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
iHealth Labs inc
Industry
Enrollment
1,119 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Months and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 15, 2024 (Actual)
Primary completion
Dec 12, 2025 (Actual)
Completion
Dec 12, 2025 (Actual)
Last update posted
Jan 8, 2026

2024 – 2025

United States locations

U.S. sites
21
U.S. states
9
U.S. cities
20
Facility City State ZIP Site status
iHealth Site 006 Birmingham Alabama 35242 —
iHealth Site 021 Trussville Alabama 35173 —
iHealth Site 017 Dublin California 94568 —
iHealth Site 007 Huntington Park California 90255 —
iHealth Site 026 Toluca Lake California 91602 —
iHealth Site 011 DeLand Florida 32720 —
iHealth Site 013 Doral Florida 33122 —
iHealth Site 004 Fort Lauderdale Florida 33308 —
iHealth Site 005 Fort Lauderdale Florida 33312 —
iHealth Site 019 Palm Springs Florida 33461 —
iHealth Site 014 Tamarac Florida 33321 —
iHealth Site 009 Ammon Idaho 83406 —
iHealth Site 027 Edison New Jersey 08820 —
iHealth Site 015 Simpsonville South Carolina 29681 —
iHealth Site 016 Spartanburg South Carolina 29301 —
iHealth Site 020 Chattanooga Tennessee 37412 —
iHealth Site 003 Brownsville Texas 78520 —
iHealth Site 002 Edinburg Texas 78539 —
iHealth Site 018 El Paso Texas 79902 —
iHealth Site 023 Mesquite Texas 75149 —
iHealth Site 025 Morgantown West Virginia 26505 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07308158, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07308158 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →